Rising Chronic Kidney Disease Rates Highlight Growing Health Concern

Chronic kidney disease (CKD) now ranks as the ninth leading cause of death around the globe, according to a recent study. The research indicates a record-high number of individuals facing diminished kidney function.

A team from New York University Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation at the University of Washington conducted an extensive analysis on the surge in kidney disease worldwide.

By examining over 2,200 published studies and health data from 133 countries, the researchers assessed the implications of CKD in terms of diagnosis costs, mortality rates, and associated disabilities.

From 1990 to 2023, the prevalence of CKD jumped from 378 million to 788 million, marking its first appearance among the top 10 deadliest diseases globally.

This analysis was part of the Global Burden of Disease 2023 study and suggested that nearly 14% of adults worldwide are living with chronic kidney disease. Unfortunately, about 1.5 million people are projected to succumb to CKD in 2023—a figure reflecting a more than 6% rise since 1993.

Interestingly, it appears that many study participants were in the early stages of the disease, where medical treatments and lifestyle adjustments could potentially stave off the need for more aggressive interventions like dialysis or surgery.

During the recent Kidney Week meeting organized by the American Society of Nephrology, the findings were described as “the most comprehensive estimate of the condition in nearly a decade.”

CKD leads to a gradual loss of the kidneys’ ability to remove waste and excess fluid from the bloodstream, New York University Langone explains. While mild cases might be asymptomatic, advanced stages often necessitate dialysis or organ transplants.

Moreover, kidney dysfunction has been recognized as a significant risk factor for heart disease, responsible for about 12% of global cardiovascular mortality.

Key risk factors for developing kidney disease include elevated blood sugar levels, high blood pressure, and increased body mass index (BMI).

Dr. Joseph Koresh, one of the study’s co-authors and director of the New York University Langone Institute for Optimal Aging, emphasized that the findings categorize chronic kidney disease as common, deadly, and an increasingly pressing public health issue.

He added that these results should motivate policymakers to prioritize CKD management similarly to conditions like cancer and heart disease.

Dr. Morgan Graham, also a co-author, pointed out that CKD often goes undiagnosed and untreated. “Our report emphasizes the importance of increased urine testing for early identification and making treatments more accessible post-diagnosis,” she stated.

Graham further noted the recent introduction of new medications that can hinder disease progression and lower the risk of heart-related problems, though she cautioned that widespread impact may take time.

In an interview with Fox News Digital, Dr. Mark Siegel, a senior medical analyst, remarked on the “dramatic increase” in CKD rates and agreed that early-stage kidney disease tends to be underrecognized. He highlighted the kidneys’ crucial role in filtering waste and maintaining balance in the body, explaining that they are sensitive to various health conditions.

“High blood pressure, obesity, heart disease, and diabetes can significantly impact kidney function, which increases the prevalence of secondary kidney issues,” he noted, stressing the importance of healthcare professionals being vigilant about kidney health.

The research received support from the National Institutes of Health, the Gates Foundation, and the National Kidney Foundation.